- Report
- April 2024
- 310 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- April 2024
- 318 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- February 2024
- 280 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- February 2024
- 322 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- February 2024
- 213 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- January 2024
- 348 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- October 2024
- 218 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5393EUR$5,713USD£4,350GBP
- Report
- August 2024
- 195 Pages
Global
From €2345EUR$2,400USD£1,958GBP
- Report
- October 2024
- 180 Pages
Global
From €4104EUR$4,200USD£3,426GBP
- Report
- September 2024
- 210 Pages
Global
From €2931EUR$3,000USD£2,447GBP
- Report
- August 2024
- 1200 Pages
Global
From €4104EUR$4,200USD£3,426GBP
- Report
- June 2024
- 140 Pages
Global
From €2931EUR$3,000USD£2,447GBP
- Report
- May 2024
- 100 Pages
Global
From €3224EUR$3,300USD£2,692GBP
- Report
- November 2024
- 173 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- July 2024
- 133 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- March 2024
- 132 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- February 2024
- 158 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- January 2024
- 485 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- November 2023
- 67 Pages
Global
From €2882EUR$2,950USD£2,406GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more